Scott Segal
President presso Segal Law Firm
Profilo
Scott Segal is currently the Director at EXUMA Biotech Corp.
He is also a Member of the American Bar Association and the President of Segal Law Firm.
In the past, he served as a Director at SRKP 5, Inc. from 2011 to 2012.
He was also a Director at Protea Biosciences, Inc. and an Independent Director at Protea Biosciences Group, Inc. Mr. Segal graduated from West Virginia University College of Law in 1981.
Posizioni attive di Scott Segal
Società | Posizione | Inizio |
---|---|---|
American Bar Association
American Bar Association Miscellaneous Commercial ServicesCommercial Services American Bar Association provides legal services. It provides law school accreditation, continuing legal education, legal information and other services to assist legal professionals. The firm has members which include judges, court administrators, law professors, and non-practicing attorneys. The company was founded on August 21, 1878 and is headquartered in Chicago, IL. | Corporate Officer/Principal | 01/01/1981 |
Segal Law Firm | President | - |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | Director/Board Member | - |
Precedenti posizioni note di Scott Segal
Società | Posizione | Fine |
---|---|---|
SRKP 5, Inc.
SRKP 5, Inc. Miscellaneous Commercial ServicesCommercial Services SRKP 5, Inc. was incorporated in the State of Delaware on May 24, 2005. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The firm was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The firm, based on proposed business activities, is a 'blank check' company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. | Director/Board Member | 12/04/2012 |
PROTEA BIOSCIENCES GROUP, INC | Director/Board Member | - |
Protea Biosciences, Inc.
Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Director/Board Member | - |
Formazione di Scott Segal
West Virginia University College of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
SRKP 5, Inc.
SRKP 5, Inc. Miscellaneous Commercial ServicesCommercial Services SRKP 5, Inc. was incorporated in the State of Delaware on May 24, 2005. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The firm was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The firm, based on proposed business activities, is a 'blank check' company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. | Commercial Services |
Protea Biosciences, Inc.
Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Health Technology |
American Bar Association
American Bar Association Miscellaneous Commercial ServicesCommercial Services American Bar Association provides legal services. It provides law school accreditation, continuing legal education, legal information and other services to assist legal professionals. The firm has members which include judges, court administrators, law professors, and non-practicing attorneys. The company was founded on August 21, 1878 and is headquartered in Chicago, IL. | Commercial Services |
Protea Biosciences Group, Inc.
Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
Segal Law Firm | |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | Commercial Services |
- Borsa valori
- Insiders
- Scott Segal